Biodesix Rg

Biodesix, Inc. delivers blood‑based diagnostics for lung cancer—Nodify risk assessment and GeneStrat immune profiling—plus COVID‑19 PCR and antibody tests, offering a data‑driven platform that supports clinicians and biopharma partners worldwide.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 273
HQ: Louisville

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
BDSX	Biodesix Rg Cap: 0.0B	EQUITY	NMS	USD	US09075X1081	Active	📈